Pistoia Alliance October Virtual Conference: R&D Leaders Roundtable: Enabling Collaborative Research – Learnings from COVID
This is part of the Pistoia Alliance Collaborate to Innovate Virtual Conference Week, October 19-23, 2020. For more information about related events, please visit our online calendar.
Summary
In this virtual roundtable, leaders from global pharma organizations, including Gilead Sciences, Roche, AbbVie and CAS discuss learnings to date from COVID-19. During COVID-19, collaboration has been the lifeblood of R&D.
The panelists discuss the increased willingness among the pharmaceutical industry to share data and highlight the need for better collaboration infrastructure to make widespread data sharing a reality. They also discuss the importance of removing barriers to sharing information outside of the pharma ecosystem, the need to bring other industries into the fold, and highlight their desire to ensure this collaborative instinct seen during COVID-19 continues post-pandemic.
Speakers
-
-
Dr. Steve Arlington (Chair)
President, Pistoia Alliance
-
-
Manuel Guzman
President, CAS
-
-
Thomas Hudson
SVP, R&D and Chief Scientific Officer, AbbVie
-
-
Palani Kumaresan
Life Cycle Leader, Roche Diagnostics International
-
-
Dr. Merdad Parsey
Chief Medical Officer, Gilead Sciences
-
-
Bryn Roberts
SVP, Global Head of Operations for Pharma Research & Early Development, Roche